Elucidation of Novel Therapeutic Targets for Breast Cancer with ESR1-CCDC170 Fusion

Among the various types of breast cancer, the luminal B subtype is the most common in young women, and ESR1-CCDC170 (E:C) fusion is the most frequent oncogenic fusion driver of the luminal B subtype. Nevertheless, treatments targeting E:C fusion has not been well established yet. Hence, the aim of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Jae Heon, Yun, Jae Won, Kim, Ha Young, Heo, Chan Yeong, Lee, Sejoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913953/
https://www.ncbi.nlm.nih.gov/pubmed/33557149
http://dx.doi.org/10.3390/jcm10040582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913953/
https://www.ncbi.nlm.nih.gov/pubmed/33557149
http://dx.doi.org/10.3390/jcm10040582

Ejemplares similares